Investment Thesis
Eastman Chemical demonstrates solid operational fundamentals with positive free cash flow generation and manageable leverage, but the extraordinary 4307.7% revenue growth combined with flat net income suggests one-time gains or accounting adjustments rather than sustainable business expansion. The modest profitability margins (5.4% net, 6.5% operating) and declining diluted EPS (-46.5% YoY) raise concerns about growth quality and underlying operational performance despite the revenue spike.
EMN Strengths
- Strong free cash flow generation of $424M with 4.8% FCF margin provides financial flexibility
- Moderate leverage with 0.70x debt-to-equity ratio and manageable long-term debt position
- Positive operating cash flow of $970M demonstrates cash generation capability from core operations
- Current ratio of 1.37x indicates adequate short-term liquidity to meet obligations
EMN Risks
- Revenue surge of 4307.7% YoY appears anomalous and likely reflects acquisition, accounting change, or one-time event rather than organic growth
- Net income essentially flat YoY (-0.2%) while revenue explodes indicates significant margin compression or non-operating charges
- Diluted EPS declined 46.5% YoY signaling shareholder value destruction despite nominal net income stability
- Low profitability margins (5.4% net margin, 6.5% operating margin) provide limited buffer for operational stress
- Quick ratio of 0.63x suggests potential liquidity concerns if working capital pressure emerges
- High insider trading activity (30 Form 4 filings in 90 days) warrants monitoring for potential concerns
Key Metrics to Watch
- Revenue quality and organic growth rate (exclude one-time items) in subsequent quarters
- Net margin trend and operating efficiency improvements to confirm sustainable profitability
- Free cash flow sustainability and capital allocation decisions relative to debt reduction
- Gross margin trajectory as proxy for pricing power and input cost management
- Debt-to-EBITDA ratio and interest coverage ratio once normalized earnings data available
EMN Financial Metrics
EMN Profitability Ratios
EMN Balance Sheet & Liquidity
EMN 5-Year Financial Trend
5-Year Trend Summary: EASTMAN CHEMICAL CO's revenue has declined by 10% over the 5-year period, indicating business contraction. The most recent EPS of $7.49 reflects profitable operations.
EMN Growth Metrics (YoY)
EMN Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $2.2B | $47.0M | $0.40 |
| Q2 2025 | $2.3B | $140.0M | $1.20 |
| Q1 2025 | $2.3B | $165.0M | $1.39 |
| Q3 2024 | $2.3B | $178.0M | $1.49 |
| Q2 2024 | $2.3B | $230.0M | $1.94 |
| Q1 2024 | $2.3B | $134.0M | $1.12 |
| Q3 2023 | $2.3B | $178.0M | $1.49 |
| Q2 2023 | $2.3B | $256.0M | $2.03 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
EMN Capital Allocation
EMN SEC Filings
Access official SEC EDGAR filings for EASTMAN CHEMICAL CO (CIK: 0000915389)